Dose-Dependent Outcomes of Streptozotocin–Nicotinamide Induction in Developing Diabetic Rat Models: A Literature Review

I Putu Aldy Mahendra, Ni Nyoman Wahyu Udayani, I Made Arendya Sumerta, Ni Made Neva Jayanti, Ni Kadek Ari Widiastuti, Ni Kadek Ria Ariska Sari

Abstract


Diabetes mellitus (DM) is a chronic metabolic disorder characterized by persistent hyperglycaemia resulting from impaired insulin secretion, insulin action, or both. Experimental rat models are widely used in preclinical diabetes research because they allow rapid and reproducible evaluation of disease mechanisms and therapeutic interventions. Among the available models, the combination of streptozotocin (STZ) and nicotinamide (NA) is commonly employed to induce a condition resembling type 2 diabetes mellitus (T2DM) through partial pancreatic β-cell damage while preserving residual insulin function. This literature review aimed to evaluate the effects of different STZ–NA induction doses on blood glucose levels in rats and to identify the most reproducible protocol for T2DM induction. A literature review was conducted using studies retrieved from scientific databases, including PubMed, NCBI, ScienceDirect, and PLOS One. A total of 21 studies met the inclusion criteria and were included in the qualitative synthesis. Across the included studies, successful diabetes induction was generally defined by hyperglycaemia; however, diagnostic thresholds varied, ranging from fasting blood glucose levels >126 mg/dL to random blood glucose levels ≥200 mg/dL. Most STZ–NA dose combinations successfully induced diabetic conditions, with post-induction glucose levels commonly exceeding 200 mg/dL. The combination of STZ 60 mg/kgBW and NA 120 mg/kgBW was the most frequently reported regimen and consistently produced stable hyperglycaemia, typically ≥200 mg/dL, while avoiding complete pancreatic β-cell destruction. Overall, the available evidence suggests that STZ 60 mg/kgBW combined with NA 120 mg/kgBW represents the most consistent protocol for establishing a T2DM rat model.

Keywords


Type 2 diabetes mellitus; Streptozotocin; Nicotinamide; Induction dose; Hyperglycemia

Full Text:

PDF

References


N. H. Cho et al., “IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045,” Diabetes Research and Clinical Practice, vol. 138, pp. 271–281, 2018. [Online]. Available: https://doi.org/10.1016/j.diabres.2018.02.023

J. Harreiter and M. Roden, “Diabetes mellitus—Definition, classification, diagnosis, screening and prevention: Update 2019,” Wiener Klinische Wochenschrift, vol. 131, suppl. 1, pp. 6–15, 2019. [Online]. Available: https://doi.org/10.1007/s00508-019-1450-4

L. Liu et al., “Association of WISP1/CCN4 with risk of overweight and gestational diabetes mellitus in Chinese pregnant women,” Disease Markers, vol. 2020, art. no. 4934206, 2020. [Online]. Available: https://doi.org/10.1155/2020/4934206

R. Williams et al., “Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition,” Diabetes Research and Clinical Practice, vol. 162, art. no. 108072, 2020. [Online]. Available: https://doi.org/10.1016/j.diabres.2020.108072

A. Petersmann et al., “Definition, classification and diagnosis of diabetes mellitus,” Experimental and Clinical Endocrinology & Diabetes, vol. 127, suppl. 1, pp. S1–S7, 2019. [Online]. Available: https://doi.org/10.1055/a-1018-9078

A. M. Ali et al., “Antidiabetic potency, antioxidant effects, and mode of actions of Citrus reticulata fruit peel hydroethanolic extract, hesperidin, and quercetin in nicotinamide/streptozotocin-induced Wistar diabetic rats,” Oxidative Medicine and Cellular Longevity, vol. 2020, art. no. 1730492, 2020. [Online]. Available: https://doi.org/10.1155/2020/1730492

J. Y. Fang, C. H. Lin, T. H. Huang, and S. Y. Chuang, “In vivo rodent models of type 2 diabetes and their usefulness for evaluating flavonoid bioactivity,” Nutrients, vol. 11, no. 3, art. no. 530, 2019. [Online]. Available: https://doi.org/10.3390/nu11030530

R. Vieira et al., “Sugar-lowering drugs for type 2 diabetes mellitus and metabolic syndrome—Review of classical and new compounds: Part I,” Pharmaceuticals, vol. 12, no. 4, art. no. 152, 2019. [Online]. Available: https://doi.org/10.3390/ph12040152

L. A. Dra et al., “Antidiabetic potential of Caralluma europaea against alloxan-induced diabetes in mice,” Saudi Journal of Biological Sciences, vol. 26, no. 6, pp. 1171–1178, 2019. [Online]. Available: https://doi.org/10.1016/j.sjbs.2018.05.028

Y. J. Sheen, C. C. Hsu, Y. D. Jiang, C. N. Huang, J. S. Liu, and W. H. H. Sheu, “Trends in prevalence and incidence of diabetes mellitus from 2005 to 2014 in Taiwan,” Journal of the Formosan Medical Association, vol. 118, suppl. 2, pp. S66–S73, 2019. [Online]. Available: https://doi.org/10.1016/j.jfma.2019.06.016

I. Akushevich et al., “Identifying the causes of the changes in the prevalence patterns of diabetes in older U.S. adults: A new trend partitioning approach,” Journal of Diabetes and Its Complications, vol. 32, no. 4, pp. 362–367, 2018. [Online]. Available: https://doi.org/10.1016/j.jdiacomp.2017.12.014

J. B. Cole and J. C. Florez, “Genetics of diabetes mellitus and diabetes complications,” Nature Reviews Nephrology, vol. 16, no. 7, pp. 377–390, 2020. [Online]. Available: https://doi.org/10.1038/s41581-020-0278-5

A. Hamadjida, R. E. A. Mbomo, S. E. Minko, F. Ntchapda, J. P. K. Mingoas, and N. Nnanga, “Antioxidant and anti-inflammatory effects of Boswellia dalzielii and Hibiscus sabdariffa extracts in alloxan-induced diabetic rats,” Metabolism Open, vol. 21, art. no. 100278, 2024. [Online]. Available: https://doi.org/10.1016/j.metop.2024.100278

M. A. Atkinson and R. G. Mirmira, “The pathogenic ‘symphony’ in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas,” Cell Metabolism, vol. 35, no. 9, pp. 1500–1518, 2023. [Online]. Available: https://doi.org/10.1016/j.cmet.2023.06.018

M. S. Popoviciu, N. Kaka, Y. Sethi, N. Patel, H. Chopra, and S. Cavalu, “Type 1 diabetes mellitus and autoimmune diseases: A critical review of the association and the application of personalized medicine,” Journal of Personalized Medicine, vol. 13, no. 3, art. no. 422, 2023. [Online]. Available: https://doi.org/10.3390/jpm13030422

W. H. El-Tantawy, “Nutrition in the management of type 2 diabetes mellitus: A review,” Archives of Physiology and Biochemistry, vol. 127, no. 6, pp. 509–526, 2021. [Online]. Available: https://doi.org/10.1080/13813455.2019.1657899

O. A. Ojo, H. S. Ibrahim, D. E. Rotimi, A. D. Ogunlakin, and A. B. Ojo, “Diabetes mellitus: From molecular mechanism to pathophysiology and pharmacology,” Medicine in Novel Technology and Devices, vol. 19, art. no. 100247, 2023. [Online]. Available: https://doi.org/10.1016/j.medntd.2023.100247

U. G. Garcia, A. Benito-Vicente, S. Jebari, and A. Larrea-Sebal, “Costus igneus: Insulin plant and its preparations as a remedial approach for diabetes mellitus,” International Journal of Pharmaceutical Sciences and Research, 2020. [Online]. Available: https://ijpsr.com/bft-article/costus-ignus-insulin-plant-and-its-preparations-as-remedial-approach-for-diabetes-mellitus/

I. G. Gvazava, M. V. Karimova, A. V. Vasiliev, and E. A. Vorotelyak, “Type 2 diabetes mellitus: Pathogenic features and experimental models in rodents,” Acta Naturae, vol. 14, no. 3, pp. 57–68, 2022. [Online]. Available: https://doi.org/10.32607/actanaturae.11751

C. P. D. Kottaisamy, D. S. Raj, V. P. Kumar, and U. Sankaran, “Experimental animal models for diabetes and its related complications—A review,” Laboratory Animal Research, vol. 37, no. 1, art. no. 23, 2021. [Online]. Available: https://doi.org/10.1186/s42826-021-00101-4

Z. S. Noshahr, H. Salmani, A. Khajavi Rad, and A. Sahebkar, “Animal models of diabetes-associated renal injury,” Journal of Diabetes Research, vol. 2020, art. no. 9416419, 2020. [Online]. Available: https://doi.org/10.1155/2020/9416419

N. T. Saputra, I. N. Suartha, and A. A. G. O. Dharmayudha, “Streptozotocin diabetogenic agent for inducing diabetes mellitus in male white rats,” Buletin Veteriner Udayana, vol. 10, no. 2, p. 116, 2018. [Online]. Available: https://doi.org/10.24843/bulvet.2018.v10.i02.p02

L. J. Yan, “The nicotinamide/streptozotocin rodent model of type 2 diabetes: Renal pathophysiology and redox imbalance features,” Biomolecules, vol. 12, no. 9, art. no. 1225, 2022. [Online]. Available: https://doi.org/10.3390/biom12091225

L. Fan, J. M. Cacicedo, and Y. Ido, “Impaired nicotinamide adenine dinucleotide (NAD+) metabolism in diabetes and diabetic tissues: Implications for nicotinamide-related compound treatment,” Journal of Diabetes Investigation, vol. 11, no. 6, pp. 1403–1419, 2020. [Online]. Available: https://doi.org/10.1111/jdi.13303

A. Ghasemi, S. Khalifi, and S. Jedi, “Streptozotocin-nicotinamide-induced rat model of type 2 diabetes: A review,” Acta Physiologica Hungarica, vol. 101, no. 4, pp. 408–420, 2015. [Online]. Available: https://doi.org/10.1556/APhysiol.101.2014.4.2

P. P. Karle, S. C. Dhawale, and V. V. Navghare, “Amelioration of diabetes and its complications by Manilkara zapota (L.) P. Royen fruit peel extract and its fractions in alloxan- and STZ-NA-induced diabetes in Wistar rats,” Journal of Diabetes & Metabolic Disorders, vol. 21, no. 1, pp. 493–510, 2022. [Online]. Available: https://doi.org/10.1007/s40200-022-01000-8

O. A. Soetan, F. O. Ajao, and A. F. Ajayi, “Blood glucose lowering and antioxidant potential of erythritol: An in vitro and in vivo study,” Journal of Diabetes & Metabolic Disorders, vol. 22, no. 2, pp. 1217–1229, 2023. [Online]. Available: https://doi.org/10.1007/s40200-023-01237-x

F. I. Ojuade, O. E. Olorundare, O. B. Akanbi, S. O. Afolabi, and A. A. Njan, “Antidiabetic and antihyperlipidemic effects of aqueous extract of Parquetina nigrescens in streptozotocin–nicotinamide-induced type 2 diabetic rats,” Heliyon, vol. 7, no. 6, art. no. e07363, 2021. [Online]. Available: https://doi.org/10.1016/j.heliyon.2021.e07363

S. Asadi et al., “Resveratrol attenuates visfatin and vaspin genes expression in adipose tissue of rats with type 2 diabetes,” Iranian Journal of Basic Medical Sciences, vol. 18, no. 6, pp. 537–543, 2015. [Online]. Available: https://pmc.ncbi.nlm.nih.gov/articles/PMC4509947/

E. Jeong, Y. Baek, H. J. Kim, and H. G. Lee, “Comparison of the anti-diabetic effects of various grain and legume extracts in high-fat diet and streptozotocin-nicotinamide-induced diabetic rats,” Heliyon, vol. 10, no. 3, art. no. e25279, 2024. [Online]. Available: https://doi.org/10.1016/j.heliyon.2024.e25279

K. Gopalasatheeskumar, G. Ariharasivakumar, V. K. Kalaichelvan, T. Sengottuvel, V. S. Devan, and V. Srividhya, “Antihyperglycemic and antihyperlipidemic activities of wild musk melon (Cucumis melo var. agrestis) in streptozotocin-nicotinamide-induced diabetic rats,” Chinese Herbal Medicines, vol. 12, no. 4, pp. 399–405, 2020. [Online]. Available: https://doi.org/10.1016/j.chmed.2020.02.005

P. Khound et al., “Phenolic-enriched fraction of Clerodendrum glandulosum Lindl. leaf extract ameliorates hyperglycemia and oxidative stress in streptozotocin-nicotinamide-induced diabetic rats,” Journal of Ayurveda and Integrative Medicine, vol. 15, no. 3, art. no. 100906, 2024. [Online]. Available: https://doi.org/10.1016/j.jaim.2024.100906

A. C. A. Nilasari, B. Wiboworini, and S. Listyawati, “Effects of red spinach extract Mira variety on fasting blood glucose and malondialdehyde of type 2 diabetes mellitus model rats,” Media Penelitian dan Pengembangan Kesehatan, vol. 34, no. 2, pp. 311–323, 2024. [Online]. Available: https://jurnal.polkesban.ac.id/index.php/jmp2k/article/view/2003

A. Ramadhani, R. Hidayatt, and D. S. Khaira, “Effect of Ramania leaf ethanol extract on insulin and fasting blood glucose in obese type 2 diabetes mellitus model rats,” Media Penelitian dan Pengembangan Kesehatan, vol. 35, no. 1, pp. 143–156, 2025. [Online]. Available: https://doi.org/10.34011/jmp2k.v35i1.2497

K. Y. Raval and P. R. Tirgar, “A pre-clinical study to investigate the anti-diabetic potential of p-propoxybenzoic acid as a multi-target inhibitor in streptozotocin-nicotinamide-induced type 2 diabetic rats,” Journal of Diabetes & Metabolic Disorders, vol. 22, no. 1, pp. 571–580, 2023. [Online]. Available: https://doi.org/10.1007/s40200-022-01177-y

A. Deshmukh and P. Manjalkar, “Synergistic effect of micronutrients and metformin in alleviating diabetic nephropathy and cardiovascular dysfunctioning in diabetic rats,” Journal of Diabetes & Metabolic Disorders, vol. 20, no. 1, pp. 533–541, 2021. [Online]. Available: https://doi.org/10.1007/s40200-021-00776-5

A. M. Abd El-Hameed, A. I. Yousef, S. M. Abd El-Twab, A. A. G. El-Shahawy, and A. Abdel-Moneim, “Hepatoprotective effects of polydatin-loaded chitosan nanoparticles in diabetic rats: Modulation of glucose metabolism, oxidative stress, and inflammation biomarkers,” Biochemistry, vol. 86, no. 2, pp. 179–189, 2021. [Online]. Available: https://doi.org/10.1134/S0006297921020061

V. Mani, M. Arfeen, S. Sajid, and Y. Almogbel, “Aqueous Ajwa date seed extract improves memory impairment in type 2 diabetes mellitus rats by reducing blood glucose levels and enhancing brain cholinergic transmission,” Saudi Journal of Biological Sciences, vol. 29, no. 4, pp. 2738–2748, 2022. [Online]. Available: https://doi.org/10.1016/j.sjbs.2021.12.060

C. N. Djouwoug et al., “Hydroethanolic extract from Bridelia atroviridis Müll. Arg. bark improves haematological and biochemical parameters in nicotinamide-/streptozotocin-induced diabetic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2020, art. no. 3160834, 2020. [Online]. Available: https://doi.org/10.1155/2020/3160834

W. Widowati et al., “Antidiabetic and hepatoprotection effect of butterfly pea flower (Clitoria ternatea L.) through antioxidant, anti-inflammatory, lower LDH, ACP, AST, and ALT on diabetes mellitus and dyslipidemia rat,” Heliyon, vol. 10, no. 8, art. no. e29812, 2024. [Online]. Available: https://doi.org/10.1016/j.heliyon.2024.e29812

K. D. Chanu et al., “Ageratina adenophora (Spreng.) King & H. Rob. standardized leaf extract as an antidiabetic agent for type 2 diabetes: An in vitro and in vivo evaluation,” Frontiers in Pharmacology, vol. 14, art. no. 1178904, 2023. [Online]. Available: https://doi.org/10.3389/fphar.2023.1178904

O. M. Ahmed, S. M. Abd El-Twab, H. M. Al-Muzafar, K. A. Amin, S. M. Abdel Aziz, and M. Abdel-Gabbar, “Musa paradisiaca L. leaf and fruit peel hydroethanolic extracts improved the lipid profile, glycemic index and oxidative stress in nicotinamide/streptozotocin-induced diabetic rats,” Veterinary Medicine and Science, vol. 7, no. 2, pp. 500–511, 2021. [Online]. Available: https://doi.org/10.1002/vms3.389

A. Raza, M. N. Mushtaq, S. Hassan, A. Sharif, B. Akhtar, and M. F. Akhtar, “Mitigation of diabetes mellitus using Euphorbia helioscopia leaf ethanolic extract by modulating GCK, GLUT4, IGF, and G6P expressions in streptozotocin-induced diabetic rats,” Journal of Diabetes Research, vol. 2024, art. no. 5497320, 2024. [Online]. Available: https://doi.org/10.1155/2024/5497320

R. C. Rout et al., “Antidiabetic and antihyperlipidemic effects of Premna spinosa bark in experimental animal models,” Journal of Advanced Pharmaceutical Technology & Research, vol. 13, no. 2, pp. 106–110, 2022. [Online]. Available: https://doi.org/10.4103/japtr.japtr_300_21

A. Kumar et al., “Formulation and evaluation of SGLT2 inhibitory effect of a polyherbal mixture inspired from Ayurvedic system of medicine,” Journal of Traditional and Complementary Medicine, vol. 12, no. 5, pp. 477–487, 2022. [Online]. Available: https://doi.org/10.1016/j.jtcme.2022.03.003

D. D. Tiwari, V. M. Thorat, P. V. Pakale, and S. J. Patil, “Study of antidiabetic properties of Berberis asiatica and Withania somnifera in streptozotocin-nicotinamide-induced type II diabetes mellitus in Wistar rats,” Cureus, vol. 16, no. 7, art. no. e64379, 2024. [Online]. Available: https://doi.org/10.7759/cureus.64379

J. Donate-Correa et al., “Inflammatory targets in diabetic nephropathy,” Journal of Clinical Medicine, vol. 9, no. 2, art. no. 458, 2020. [Online]. Available: https://doi.org/10.3390/jcm9020458

C. C. Lo, S. H. Lin, J. S. Chang, and Y. W. Chien, “Effects of melatonin on glucose homeostasis, antioxidant ability, and adipokine secretion in ICR mice with NA/STZ-induced hyperglycemia,” Nutrients, vol. 9, no. 11, art. no. 1187, 2017. [Online]. Available: https://doi.org/10.3390/nu9111187

N. Rais et al., “Model of streptozotocin-nicotinamide-induced type 2 diabetes: A comparative review,” Current Diabetes Reviews, vol. 18, no. 8, 2022. [Online]. Available: https://doi.org/10.2174/1573399818666211117123358

N. I. Ratnaningtyas and F. Husen, “Mycochemical profile and antidiabetic activity of Coprinus comatus mushroom in hyperglycemic rats model with streptozotocin induction,” Jurnal Mikologi Indonesia, vol. 6, no. 1, pp. 37–47, 2022. [Online]. Available: https://doi.org/10.46638/jmi.v6i1.204

R. R. Cheekati, A. S. Rao, and R. Vijayaraghavan, “A histological study of alloxan-induced diabetes on experimental male Wistar rats,” National Journal of Physiology, Pharmacy and Pharmacology, vol. 7, no. 12, pp. 1329–1334, 2017. [Online]. Available: https://doi.org/10.5455/njppp.2017.7.0622711072017

A. Ghasemi and S. Jeddi, “Streptozotocin as a tool for induction of rat models of diabetes: A practical guide,” EXCLI Journal, vol. 22, pp. 274–294, 2023. [Online]. Available: https://doi.org/10.17179/excli2022-5720

A. M. T. A. Nahdi, A. John, and H. Raza, “Elucidation of molecular mechanisms of streptozotocin-induced oxidative stress, apoptosis, and mitochondrial dysfunction in Rin-5F pancreatic β-cells,” Oxidative Medicine and Cellular Longevity, vol. 2017, art. no. 7054272, 2017. [Online]. Available: https://doi.org/10.1155/2017/7054272

S. Patra, S. Bhattacharya, A. Bala, and P. Haldar, “Antidiabetic effect of Drymaria cordata leaf against streptozotocin-nicotinamide-induced diabetic albino rats,” Journal of Advanced Pharmaceutical Technology & Research, vol. 11, no. 1, pp. 44–52, 2020. [Online]. Available: https://doi.org/10.4103/japtr.JAPTR_98_19

P. Balaji et al., “Evaluation of antidiabetic activity of Pleurotus pulmonarius against streptozotocin-nicotinamide-induced diabetic Wistar albino rats,” Saudi Journal of Biological Sciences, vol. 27, no. 3, pp. 913–924, 2020. [Online]. Available: https://doi.org/10.1016/j.sjbs.2020.01.027




DOI: https://doi.org/10.37311/ijpe.v6i2.37313

Refbacks

  • There are currently no refbacks.


Copyright (c) 2026 I Putu Aldy Mahendra, Ni Nyoman Wahyu Udayani, I Made Arendya Sumerta, Ni Made Neva Jayanti, Ni Kadek Ari Widiastuti, Ni Kadek Ria Ariska Sari

Creative Commons License
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.